Products Cladribine was approved for the treatment of multiple sclerosis in the EU in 2017 and in the United States and many countries in 2019 in tablet form (Mavenclad). Cladribine has also been commercially available as an infusion and injection solution in many countries since 1998 (Litak). This article relates to MS therapy. Structure and … Cladribine
What is Brivudin? Brivudine is the active ingredient in drugs used to treat specific diseases caused by herpes viruses. It is a nucleoside analogue and is much more effective than similar antiviral drugs. Nucleoside analogues have a structural similarity with the building blocks of DNA. If a nucleoside analogue is inserted instead of the actual … Brivudin
How does Brivudin work? Brivudine is a so-called nucleoside analogue. Nucleosides belong to the building blocks of the DNA of our cells. If brivudine is used instead of a normal nucleoside in the DNA structure, the further re-synthesis of the genetic information stops. The effect of brivudine is therefore that it interferes with the reproduction … How does Brivudin work? | Brivudin
When should Brivudin not be given? Brivudine must not be given to certain groups of patients: Therefore, it is imperative that the treating physician be informed of all medications that are taken regularly. – during pregnancy and lactation If the patient is younger than 18 years In case of known hypersensitivity to brivudine and the … When should Brivudin not be given? | Brivudin
Dosage The dosage of Brivudine is quite simple. One pack contains seven tablets of 125 mg active ingredient each and the treatment period is set at one week. Treatment is started as early as possible, regardless of the time of day or food intake, by taking the first tablet. This is taken unchewed with a … Dosage | Brivudin